BlackRock Inc. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$197,460,304
+3.0%
1,702,244
+4.2%
0.01%
+20.0%
Q2 2023$191,746,366
+39.6%
1,633,274
-4.8%
0.01%
+25.0%
Q1 2023$137,390,566
+2.0%
1,716,095
+1.0%
0.00%0.0%
Q4 2022$134,641,998
+23.4%
1,699,596
+8.6%
0.00%0.0%
Q3 2022$109,101,000
-2.3%
1,565,305
-8.0%
0.00%0.0%
Q2 2022$111,709,000
-0.3%
1,701,322
+1.1%
0.00%
+33.3%
Q1 2022$112,020,000
-0.3%
1,683,511
+4.9%
0.00%0.0%
Q4 2021$112,303,000
+39.5%
1,605,496
+4.2%
0.00%
+50.0%
Q3 2021$80,476,000
-22.8%
1,541,386
+0.6%
0.00%
-33.3%
Q2 2021$104,199,000
-8.7%
1,532,346
+3.5%
0.00%0.0%
Q1 2021$114,067,000
+35.1%
1,480,628
+5.2%
0.00%0.0%
Q4 2020$84,441,000
+63.9%
1,407,348
+17.6%
0.00%
+50.0%
Q3 2020$51,527,000
+12.2%
1,196,920
+7.9%
0.00%0.0%
Q2 2020$45,933,000
+28.5%
1,108,984
+34.1%
0.00%0.0%
Q1 2020$35,750,000
-14.3%
826,765
+9.8%
0.00%0.0%
Q4 2019$41,692,000
+59.7%
752,830
+0.2%
0.00%
+100.0%
Q3 2019$26,100,000
+7.7%
751,629
+25.0%
0.00%0.0%
Q2 2019$24,224,000
+1233.9%
601,514
+989.8%
0.00%
Q1 2019$1,816,000
+356.3%
55,197
+188.1%
0.00%
Q4 2018$398,000
+66.5%
19,157
+41.0%
0.00%
Q3 2018$239,000
+23.2%
13,589
+4.2%
0.00%
Q2 2018$194,000
+158.7%
13,040
+75.4%
0.00%
Q1 2018$75,000
+837.5%
7,433
+832.6%
0.00%
Q4 2017$8,0007970.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders